SimCure develops SimSize, a medical software that utilizes advanced algorithms to optimize the selection of endovascular devices for treating cerebral aneurysms. This technology enhances clinical decision-making, improving patient outcomes while managing surgical costs for healthcare providers.
Funding
Funding not disclosed
Founders
Product
Problem
Selecting the optimal endovascular devices for treating cerebral aneurysms is challenging, often leading to suboptimal outcomes and increased surgical costs. Current methods lack the precision needed to account for patient-specific anatomical variations and device characteristics, hindering effective clinical decision-making.
Solution
SimCure's SimSize is a medical software that leverages advanced algorithms and Digital Twin technology to optimize the selection of endovascular devices for cerebral aneurysm treatment. By creating a patient-specific digital replica of the cerebral vasculature, SimSize enables clinicians to simulate and predict the performance of different devices, ensuring optimal fit and treatment efficacy. This multifactorial approach enhances procedural success, reduces the risk of complications, and improves overall patient care by providing exclusive patient-specific therapeutic solutions. The software aims to help hospitals and healthcare systems master the cost per surgery and improve patient care at the same time.
Target Audience
The primary target audience includes healthcare professionals such as neurosurgeons, interventional radiologists, and neurologists specializing in the treatment of cerebral aneurysms, as well as hospitals and healthcare systems.
Features
- Patient-specific Digital Twin creation for accurate anatomical representation
- Advanced algorithms to simulate device performance within the aneurysm
- Device selection optimization based on predicted outcomes
- Integration with imaging company tools to enhance image information